InnoTherapy Concludes General Meeting... "All Major Agendas Including Name Change Passed"

Innotherapy, an affiliate of the global healthcare SCL Group, announced on the 29th that it held the 14th regular general meeting of shareholders and resolved amendments to the articles of incorporation, including a company name change and the addition of business objectives. In addition, the approval of financial statements and the approval of the director remuneration limit agenda were passed as originally proposed.

The company added the following to its business objectives to expand its digital healthcare business: ▲ health management services ▲ AI-based medical solution development and services ▲ medical information business and medical software development and services ▲ development and services of medical support, health management, and research management platforms.

The agenda to change the company name to 'SCL Science' was also approved. 'SCL Science' embodies the vision of sharing brand identity with the parent group, SCL Group, and promoting new digital healthcare businesses.

Taking the company name change and the addition of business objectives as an opportunity, the company plans to secure future growth engines in the digital healthcare sector. In particular, the goal is to leap forward as a global leading company in digital healthcare by utilizing the medical service network and medical data owned by SCL Group.

A company official stated, "We will maximize business synergy with SCL Group to create various business opportunities in the digital healthcare field," adding, "We will build integrated group data and platforms and actively enter non-face-to-face medical services, medical MyData, and medical AI businesses to establish ourselves as a leading company in digital healthcare."